Literature DB >> 427004

Biotransformation of diflunisal and renal excretion of its glucuronides in renal insufficiency.

R Verbeeck, T B Tjandramaga, A Mullie, R Verbesselt, R Verberckmoes, P J de Schepper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 427004      PMCID： PMC1429486          DOI： 10.1111/j.1365-2125.1979.tb00932.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  12 in total

1.  Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.

Authors:  C M KUNIN; A J GLAZKO; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Physiological disposition and metabolism of 5-(2',4'-difluorophenyl)salicyclic acid, a new salicylate.

Authors:  D J Tocco; G O Breault; A G Zacchei; S L Steelman; C V Perrier
Journal:  Drug Metab Dispos       Date:  1975 Nov-Dec       Impact factor: 3.922

4.  Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man.

Authors:  G Levy; T Tsuchiya; L P Amsel
Journal:  Clin Pharmacol Ther       Date:  1972 Mar-Apr       Impact factor: 6.875

5.  Individualization of drug dosage in patients with renal disease.

Authors:  L Dettli
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

6.  A guide to drug therapy in renal failure.

Authors:  W M Bennett; I Singer; C J Coggins
Journal:  JAMA       Date:  1974-12-16       Impact factor: 56.272

7.  Diflunisal: efficacy in postoperative pain.

Authors:  C Van Winzum; B Rodda
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

8.  The effect of end-stage renal failure and haemodialysis on the elimination kinetics of sotalol.

Authors:  T B Tjandramaga; R Verbeeck; J Thomas; R Verbesselt; R Verberckmoes; P J Schepper
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

9.  Drug administration in renal failure.

Authors:  J S Cheigh
Journal:  Am J Med       Date:  1977-04       Impact factor: 4.965

10.  The biotransformation of drugs in renal failure.

Authors:  M M Reidenberg
Journal:  Am J Med       Date:  1977-04       Impact factor: 4.965
View more
  26 in total

1.  The effect of multiple dosage on the kinetics of glucuronidation and sulphation of diflunisal in man.

Authors:  R K Verbeeck; G R Loewen; J I MacDonald; R J Herman
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

2.  Pharmacokinetic interaction between indomethacin and diflunisal.

Authors:  A Van Hecken; R Verbesselt; T B Tjandra-Maga; P J De Schepper
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Effect of food and various antacids on the absorption of tenoxicam.

Authors:  R O Day; S Lam; P Paull; D Wade
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

4.  Impaired elimination of lorazepam following subchronic administration in two patients with renal failure.

Authors:  R K Verbeeck; T B Tjandramaga; P J De Schepper; R Verberckmoes
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

5.  Decreased body clearance of diflunisal in renal insufficiency--an alternative explanation.

Authors:  G Levy
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

6.  Non-steroidal Anti-inflammatory Drugs: Monitoring to help prevent serious adverse effects.

Authors:  B Cardario; A A McKinnon
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

7.  The influence of diflunisal on the pharmacokinetics of oxazepam.

Authors:  A M van Hecken; T B Tjandramaga; R Verbesselt; P J de Schepper
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

8.  Diflunisal and its conjugates in patients with renal failure.

Authors:  R G Dickinson; R K Verbeeck; A R King; A C Restifo; S M Pond
Journal:  Br J Clin Pharmacol       Date:  1991-05       Impact factor: 4.335

9.  Metabolism of amitriptyline in patients with chronic renal failure.

Authors:  M Sandoz; S Vandel; B Vandel; B Bonin; B Hory; Y St Hillier; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 10.  Diflunisal: a review of its pharmacological properties and therapeutic use in pain and musculoskeletal strains and sprains and pain in osteoarthritis.

Authors:  R N Brogden; R C Heel; G E Pakes; T M Speight; G S Avery
Journal:  Drugs       Date:  1980-02       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.